Ariel Precision Medicine Overview

  • Founded
  • 2014

Founded
  • Status
  • Private

  • Employees
  • 21

Employees
  • Latest Deal Type
  • Later Stage VC

  • Investors
  • 6

Ariel Precision Medicine General Information

Description

Developer an AI-fueled genetic segmentation platform intended to develop therapeutics for complex chronic diseases, starting with pancreatitis. The company's platform and proprietary clinical data integrate genetic results, systems biology, automation, and artificial intelligence to determine the biological dysfunction driving a patient's condition and link to evidence-based medicine and treatments tailored for each patient, thus providing the healthcare sector with an integrated genomics and health technology solution and enabling stratification of patients into different disease sub-types and then model the appropriate mechanism of action to effective therapy.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Decision/Risk Analysis
Other Industries
Laboratory Services (Healthcare)
Primary Office
  • 5750 Centre Avenue
  • Suite 270
  • Pittsburgh, PA 15206
  • United States
+1 (844) 000-0000

Ariel Precision Medicine Timeline

2019202020212022
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Ariel Precision Medicine Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
5. Later Stage VC 28-Jun-2021 0000 Completed Generating Revenue
4. Seed Round 14-Oct-2020 00.00 0000 000.00 Completed Generating Revenue
3. Debt - PPP 29-Apr-2020 00.000 Completed Generating Revenue
2. Seed Round 17-Jun-2019 $7.71M $7.71M 000.00 Completed Generating Revenue
1. Accelerator/Incubator 01-Mar-2017 Completed Generating Revenue
To view Ariel Precision Medicine’s complete valuation and funding history, request access »

Ariel Precision Medicine Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Seed 0,000,000 00.000000 00 00.00 00.00 00 00.00 00.000
To view Ariel Precision Medicine’s complete cap table history, request access »

Ariel Precision Medicine Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last Financing Details
Developer an AI-fueled genetic segmentation platform intended to develop therapeutics for complex chronic diseases, star
Decision/Risk Analysis
Pittsburgh, PA
21 As of 2022
0000
0000000000 0 0000

000000

nisi ut aliquip ex ea commodo consequat. Duis aute irure dolor in reprehenderit in voluptate velit e
0000000000000 00000000
Harderwijk, Netherlands
00 As of 0000
000000 - 000

000000

or incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation u
0000000000000 00000000
Oakland, CA
00 As of 0000
000.00
00000000000 000.00
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Ariel Precision Medicine Competitors (15)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Genalice Formerly PE-Backed Harderwijk, Netherlands 00 000000 - 000
000000 00000000 Venture Capital-Backed Oakland, CA 00 000.00 00000000000 000.00
0000000 00000000 Venture Capital-Backed Waltham, MA 000 00000 00000000000 00000
0000000 000000 Formerly VC-backed Burlington, MA 00 000.00 000000&0 000.00
0000000000000 Venture Capital-Backed Long Hanborough, United Kingdom 00 00.000 00000000000
You’re viewing 5 of 15 competitors. Get the full list »

Ariel Precision Medicine Patents

Ariel Precision Medicine Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-20200176119-A1 Methods and systems for severity calculator Pending 30-Nov-2018 000000000 0

Ariel Precision Medicine Executive Team (5)

Name Title Board Seat Contact Info
Jessica Gibson Co-Founder, Chief Executive Officer & Board Member
Tory Moore Chief Financial Officer
David Whitcomb Co-Founder, Chief Scientific Officer, Board Member & Chairman of the Medical Advisory Board
You’re viewing 3 of 5 executive team members. Get the full list »

Ariel Precision Medicine Board Members (7)

Name Representing Role Since
Christopher Moehle Ph.D The Robotics Hub Board Member 000 0000
David Whitcomb Ariel Precision Medicine Co-Founder, Chief Scientific Officer, Board Member & Chairman of the Medical Advisory Board 000 0000
Hank Safferstein Self Board Member 000 0000
Jessica Gibson Ariel Precision Medicine Co-Founder, Chief Executive Officer & Board Member 000 0000
You’re viewing 4 of 7 board members. Get the full list »

Ariel Precision Medicine Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Ariel Precision Medicine Investors (6)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
MCI Onehealth Technologies Corporation Minority 000 0000 000000 0
Innovation Works Venture Capital Minority 000 0000 000000 0
Next Act Fund Angel Group Minority 000 0000 000000 0
Pittsburgh Life Sciences Greenhouse Venture Capital Minority 000 0000 000000 0
The Robotics Hub Venture Capital Minority 000 0000 000000 0
You’re viewing 5 of 6 investors. Get the full list »